+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
US Biosimilar industry outlook to 2028 - Product Thumbnail Image

US Biosimilar industry outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
Cancer Supportive Care - Global Strategic Business Report - Product Thumbnail Image

Cancer Supportive Care - Global Strategic Business Report

  • Report
  • April 2025
  • 262 Pages
  • Global
From
From
From
From
From
From
From
Metastatic Renal Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Renal Cell Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 170 Pages
  • Global
From
Non-small Cell Lung Cancer Drugs Market 2023-2027 - Product Thumbnail Image

Non-small Cell Lung Cancer Drugs Market 2023-2027

  • Report
  • May 2023
  • 167 Pages
  • Global
From
Hairy Cell Leukemia Therapeutics Market 2024-2028 - Product Thumbnail Image

Hairy Cell Leukemia Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 146 Pages
  • Global
From
Multiple Myeloma Drugs Market 2024-2028 - Product Thumbnail Image

Multiple Myeloma Drugs Market 2024-2028

  • Report
  • July 2024
  • 179 Pages
  • Global
From
Loading Indicator